Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 33.3%GRADE not reported 1 · 33.3%Very low 0 · 0%Low 0 · 0%Moderate 1 · 33.3%High 0 · 0%

CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) vs HIGH DOSE (> 800 mg/day ‐ all medium term)

Adverse event: Death · schizophrenia

CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) showed no clear difference in adverse event: death compared with HIGH DOSE (> 800 mg/day ‐ all medium term) (moderate certainty).

1 finding from 1 review

Chlorpromazine dose for people with schizophrenia 2017 · Cochrane Headline outcomes only
RR 0.33 [0.01, 8.14]
1 study · 416 participants
Moderate

CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) vs MEDIUM DOSE (401 mg/day to 800 mg/day)

Adverse event: Death · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Chlorpromazine dose for people with schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Adverse effect/event: death · patients with schizophrenia

1 finding from 1 review

Chlorpromazine versus penfluridol for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 2 participants
GRADE not reported